Literature DB >> 22480191

P53 gene mutation increases progastrin dependent colonic proliferation and colon cancer formation in mice.

Vigneshwaran Ramanathan1, Guangchun Jin, Christoph Benedikt Westphalen, Ashley Whelan, Alexander Dubeykovskiy, Shigeo Takaishi, Timothy C Wang.   

Abstract

Transgenic mice overexpressing human progastrin (hGAS) show colonic crypt hyper-proliferation and elevated susceptibility to colon carcinogenesis. We aimed to investigate effects of p53 mutation on colon carcinogenesis in hGAS mice. We show that introducing a p53 gene mutation further increases progastrin dependent BrdU labeling and results in markedly elevated number of aberrant crypt foci (ACF) and colonic tumors. We demonstrate that hGAS/Lgr5-GFP mice have higher number of Lgr5+ colonic stem cells per crypt when compared to Lgr5-GFP mice indicating that progastrin changes crypt biology through increased stem cell numbers and additional p53 mutation leads to more aggressive phenotype in this murine colon cancer model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22480191      PMCID: PMC3697930          DOI: 10.3109/07357907.2012.657814

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  49 in total

1.  Gastrin-releasing peptide: an identity crisis at 30?

Authors:  G J Dockray
Journal:  Lancet       Date:  2001-09-08       Impact factor: 79.321

Review 2.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

Review 3.  [Genetic pathways in colorectal cancer: interest for the pathologist].

Authors:  Françoise Piard; Laurent Martin; Caroline Chapusot; Tibor Ponnelle; Jean Faivre
Journal:  Ann Pathol       Date:  2002-09       Impact factor: 0.407

4.  Gastric tuft cells express DCLK1 and are expanded in hyperplasia.

Authors:  Milena Saqui-Salces; Theresa M Keeley; Ann S Grosse; Xiaotan T Qiao; Mohamad El-Zaatari; Deborah L Gumucio; Linda C Samuelson; Juanita L Merchant
Journal:  Histochem Cell Biol       Date:  2011-06-18       Impact factor: 4.304

5.  Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM.

Authors:  P Singh; M Velasco; R Given; M Wargovich; A Varro; T C Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-03       Impact factor: 4.052

6.  Glycine-extended gastrin synergizes with gastrin 17 to stimulate acid secretion in gastrin-deficient mice.

Authors:  D Chen; C M Zhao; G J Dockray; A Varro; A Van Hoek; N F Sinclair; T C Wang; T J Koh
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

7.  Biologically active recombinant human progastrin(6-80) contains a tightly bound calcium ion.

Authors:  G S Baldwin; F Hollande; Z Yang; Y Karelina; A Paterson; R Strang; D Fourmy; G Neumann; A Shulkes
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

8.  Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma.

Authors:  R K Siddheshwar; J C Gray; S B Kelly
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

9.  Progastrin and cyclooxygenase-2 in colorectal cancer.

Authors:  Peter C Konturek; Władysław Bielanski; Stanislaw J Konturek; Artur Hartwich; Piotr Pierzchalski; Macien Gonciarz; Krzysztof Marlicz; Teresa Starzynska; Monika Zuchowicz; Zbigniew Darasz; Jens P Götze; Jens F Rehfeld; Eckhart G Hahn
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

10.  The colonic response to genotoxic carcinogens in the rat: regulation by dietary fibre.

Authors:  Y Hu; J Martin; R Le Leu; G P Young
Journal:  Carcinogenesis       Date:  2002-07       Impact factor: 4.944

View more
  8 in total

1.  CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis.

Authors:  Yoku Hayakawa; Guangchun Jin; Hongshan Wang; Xiaowei Chen; Christoph B Westphalen; Samuel Asfaha; Bernhard W Renz; Hiroshi Ariyama; Zinaida A Dubeykovskaya; Yoshihiro Takemoto; Yoomi Lee; Ashlesha Muley; Yagnesh Tailor; Duan Chen; Sureshkumar Muthupalani; James G Fox; Arthur Shulkes; Daniel L Worthley; Shigeo Takaishi; Timothy C Wang
Journal:  Gut       Date:  2014-06-20       Impact factor: 23.059

2.  Progastrin Peptides Increase the Risk of Developing Colonic Tumors: Impact on Colonic Stem Cells.

Authors:  Pomila Singh; Shubhashish Sarkar; Carla Kantara; Carrie Maxwell
Journal:  Curr Colorectal Cancer Rep       Date:  2012-12

3.  Progastrin-induced secretion of insulin-like growth factor 2 from colonic myofibroblasts stimulates colonic epithelial proliferation in mice.

Authors:  Carrie A Duckworth; Daniel Clyde; Daniel L Worthley; Timothy C Wang; Andrea Varro; D Mark Pritchard
Journal:  Gastroenterology       Date:  2013-03-19       Impact factor: 22.682

4.  Progastrin stimulates colonic cell proliferation via CCK2R- and β-arrestin-dependent suppression of BMP2.

Authors:  Guangchun Jin; C Benedikt Westphalen; Yoku Hayakawa; Daniel L Worthley; Samuel Asfaha; Xiangdong Yang; Xiaowei Chen; Yiling Si; Hongshan Wang; Yagnesh Tailor; Richard A Friedman; Timothy C Wang
Journal:  Gastroenterology       Date:  2013-07-25       Impact factor: 22.682

5.  Mouse models for colorectal cancer.

Authors:  Baktiar O Karim; David L Huso
Journal:  Am J Cancer Res       Date:  2013-06-20       Impact factor: 6.166

Review 6.  Novel roles of gastrin.

Authors:  Rod Dimaline; Andrea Varro
Journal:  J Physiol       Date:  2014-03-24       Impact factor: 5.182

7.  Bioinformatics Analysis of LGR4 in Colon Adenocarcinoma as Potential Diagnostic Biomarker, Therapeutic Target and Promoting Immune Cell Infiltration.

Authors:  Lijuan Wu; Xiaoxiao Tian; Hao Du; Xiaomin Liu; Haigang Wu
Journal:  Biomolecules       Date:  2022-08-06

8.  TLR4 activates the β-catenin pathway to cause intestinal neoplasia.

Authors:  Rebeca Santaolalla; Daniel A Sussman; Jose R Ruiz; Julie M Davies; Cristhine Pastorini; Cecilia L España; John Sotolongo; Oname Burlingame; Pablo A Bejarano; Sakhi Philip; Mansoor M Ahmed; Jeffrey Ko; Ramanarao Dirisina; Terrence A Barrett; Limin Shang; Sergio A Lira; Masayuki Fukata; Maria T Abreu
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.